Lipocine Inc (LPCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,120 | -3,488 | -634 | -13,258 | -10,177 |
| Depreciation Amortization | 92 | 53 | 516 | 359 | 204 |
| Accounts payable and accrued liabilities | -475 | -820 | -308 | -872 | -691 |
| Other Working Capital | -1,015 | -1,004 | -4,595 | -495 | 3,246 |
| Other Operating Activity | 586 | 1,373 | 610 | 860 | 993 |
| Operating Cash Flow | $-6,932 | $-3,885 | $-4,411 | $-13,406 | $-6,425 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -37 | -27 | -8 | N/A | N/A |
| Purchase Of Investment | -22,681 | -17,906 | -48,423 | -37,308 | -35,876 |
| Sale Of Investment | 33,802 | 25,229 | 4,650 | 3,250 | 450 |
| Investing Cash Flow | $11,084 | $7,295 | $-43,780 | $-34,058 | $-35,426 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,667 | -833 | -3,333 | -2,500 | -1,667 |
| Common Stock Issued | 206 | 206 | 26,852 | 30,263 | 30,268 |
| Other Financing Activity | -661 | 0 | 3,406 | 0 | 0 |
| Financing Cash Flow | $-2,121 | $-627 | $26,925 | $27,763 | $28,602 |
| Beginning Cash Position | 2,951 | 2,951 | 24,217 | 24,217 | 24,217 |
| End Cash Position | 4,981 | 5,733 | 2,951 | 4,517 | 10,968 |
| Net Cash Flow | $2,031 | $2,783 | $-21,267 | $-19,700 | $-13,250 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,932 | -3,885 | -4,411 | -13,406 | -6,425 |
| Capital Expenditure | -37 | -27 | -8 | N/A | N/A |
| Free Cash Flow | -6,969 | -3,912 | -4,419 | -13,406 | -6,425 |